Algorithmiq, a startup using quantum algorithms to help drug discovery for pharmaceutical companies, has raised $15m (£11.8m) in Series A funding. Capital came from lead investor Inventure VC, along with Tesi, Presidio Ventures, London's Thames Trust and previous backers. The company is aiming to speed up the drug development cycle by applying its quantum algorithms [...] The post Algorithmiq nets £12m for quantum drug discovery appeared first on UKTN | UK Tech News.
Algorithmiq is a Finland-based quantum computing platform that provides solutions such as drug discovery and development for the life sciences industry.